PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 16, 2003Annals of Pharmacotherapy157 citations

Pharmacist Intervention Program for Control of Hypertension

View Full Paper
ICIsabelle ChabotJMJocelyne MoisanJGJean‐Pierre Grégoire

Structured PICO

Does a pharmacist intervention program improve blood pressure control in treated hypertensive patients?

P
Population
100 treated hypertensive patients
I
Intervention
Pharmaceutical care program using a computerized decision-aid tool provided by pharmacists based on the PRECEDE-PROCEED model
C
Comparator
Usual care by pharmacists
O
Outcome
Blood pressure (BP) reduction and proportion of controlled patientssurrogate

A pharmacist-led intervention program significantly reduced systolic blood pressure in treated hypertensive patients, but the benefit was limited to those with high incomes.

Abstract

BACKGROUND: Pharmaceutical care programs have been shown to improve outcomes in hypertension. However, most programs required direct access to patient medical chart and patient consultation sessions by appointment. OBJECTIVE: To follow the current practice of community pharmacy, exploring the effect of an intervention program on blood pressure (BP) and factors affecting BP. METHODS: Treated hypertensive patients were enrolled in a 9-month controlled study involving 9 community pharmacies. The PRECEDE-PROCEED model was used as conceptual framework to identify factors affecting BP, to incorporate those factors in an intervention program, and to evaluate the impact of the program. A computerized decision-aid tool was used by pharmacists from 4 pharmacies to provide pharmaceutical care to subjects (n = 41); pharmacists from the 5 other pharmacies performed usual care (n = 59). As there was a statistically significant interaction due to family income in describing the impact of pharmacists' intervention on BP, population was stratified by family income in the analyses. RESULTS: Compared with the control group, the pharmacy program resulted in significant systolic BP reduction (-7.8 vs. 0.5 mm Hg; p = 0.01) and an increase in the proportion of controlled patients only for those with high incomes. In the high-income group, the program also had a positive impact on physical activity, self-reported adherence, health concerns, and information transmitted. The low-income group did not appear to benefit from the program. CONCLUSIONS: Pharmacist intervention can modify factors affecting adherence, improve adherence, and reduce BP levels in patients treated with antihypertensive agents. Impact of pharmacist intervention on BP differed according to patient income status.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Chabot et al. (2003) studied this question.

synapsesocial.com/papers/6a1e7b015a76b87e09953ce1https://doi.org/10.1345/aph.1c267
Ask AI
Helpful
Bookmark
Share
View Full Paper